01 3Novo Nordisk Canada Inc.
02 3Blank
01 31225398
02 32111851
01 3Repaglinide
02 3Blank
01 3Tablet
02 3Blank
01 32004-08-11
02 32011-06-21
Patent Expiration Date : 2011-06-21
Date Granted : 2002-02-26
Brand Name : GLUCONORM
Patent Number : 2111851
Filing Date : 1991-06-21
Strength per Unit : 0.5mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-06-21
Date Granted : 2002-02-26
Patent Expiration Date : 2011-06-21
Date Granted : 2002-02-26
Brand Name : GLUCONORM
Patent Number : 2111851
Filing Date : 1991-06-21
Strength per Unit : 1.0mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-06-21
Date Granted : 2002-02-26
Patent Expiration Date : 2011-06-21
Date Granted : 2002-02-26
Brand Name : GLUCONORM
Patent Number : 2111851
Filing Date : 1991-06-21
Strength per Unit : 2.0mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-06-21
Date Granted : 2002-02-26
Patent Expiration Date : 2004-08-11
Date Granted :
Brand Name :
Patent Number : 1225398
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2004-08-11
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2004-08-11
Date Granted :
Brand Name :
Patent Number : 1225398
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2004-08-11
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2004-08-11
Date Granted :
Brand Name :
Patent Number : 1225398
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2004-08-11
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
